Protein Binding and Stereoselectivity of Nonsteroidal Anti-inflammatory Drugs

Overview

Journal Clin Pharmacokinet

Specialty Pharmacology

Date 1993 Aug 1

PMID 8403735

Citations 5

Authors

F Lapicque

N Muller

E Payan

N Dubois

P Netter

Affiliations

Soon will be listed here.

Abstract

Stereoselective binding of nonsteroidal anti-inflammatory drugs (NSAIDs) can be studied using various techniques. Thus the results obtained by different investigators may be poorly consistent and even contradictory. NSAIDs are bound stereoselectively to serum albumin to different degrees depending on the drug investigated (ibuprofen, indoprofen, carprofen, etodolac, ketoprofen and flurbiprofen). For other drugs, both enantiomers are bound to a similar extent (pirprofen, fenoprofen). This stereoselectivity could vary with experimental conditions, in particular with protein concentration (ketoprofen, etodolac), leading to individual differences. Finally, the stereoselectivity of protein binding and of pharmacokinetics can be compared: differences in binding between enantiomers can explain their differences in pharmacokinetics, once metabolic properties such as inversion have been taken into account.

Citing Articles

Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period.

Kulo A, Smits A, Maleskic S, Van de Velde M, Van Calsteren K, de Hoon J Bosn J Basic Med Sci. 2016; 17(1):54-60.

PMID: 27968707 PMC: 5341779. DOI: 10.17305/bjbms.2016.1515.

Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains.

Shi D, Jin Y, Tang Y, Hu H, Xu S, Yu L Acta Pharmacol Sin. 2012; 33(5):710-6.

PMID: 22555373 PMC: 4010353. DOI: 10.1038/aps.2012.8.

Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain.

Seymour R, Kelly P, Hawkesford J Clin Drug Investig. 2008; 15(4):279-84.

PMID: 18370482 DOI: 10.2165/00044011-199815040-00003.

In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite.

MACHINIST J, Kukulka M, Bopp B Clin Pharmacokinet. 1995; 29 Suppl 2:34-41.

PMID: 8620669 DOI: 10.2165/00003088-199500292-00006.

Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Brouwers J, de Smet P Clin Pharmacokinet. 1994; 27(6):462-85.

PMID: 7882636 DOI: 10.2165/00003088-199427060-00005.

References

Caldwell J, Hutt A, Fournel-Gigleux S . The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Pharmacol. 1988; 37(1):105-14. DOI: 10.1016/0006-2952(88)90762-9. View

Evans A, Nation R, Sansom L, Bochner F, Somogyi A . Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen. Br J Clin Pharmacol. 1991; 31(2):131-8. PMC: 1368378. DOI: 10.1111/j.1365-2125.1991.tb05500.x. View

Young M, Aarons L, Toon S . The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol. 1991; 31(1):102-4. PMC: 1368420. DOI: 10.1111/j.1365-2125.1991.tb03865.x. View

Toon S, TRAGER W . Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone. J Pharm Sci. 1984; 73(11):1671-3. DOI: 10.1002/jps.2600731154. View

Sallustio B, Purdie Y, Whitehead A, Ahern M, Meffin P . The disposition of ketoprofen enantiomers in man. Br J Clin Pharmacol. 1988; 26(6):765-70. PMC: 1386593. DOI: 10.1111/j.1365-2125.1988.tb05317.x. View

Cox S, Gall E, Forbes K, Gresham M, Goris G . Pharmacokinetics of the R(-) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritis patients. J Clin Pharmacol. 1991; 31(1):88-94. DOI: 10.1002/j.1552-4604.1991.tb01892.x. View

Otagiri M, Masuda K, Imai T, Imamura Y, Yamasaki M . Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques. Biochem Pharmacol. 1989; 38(1):1-7. DOI: 10.1016/0006-2952(89)90141-x. View

Lee E, Williams K, Day R, Graham G, Champion D . Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol. 1985; 19(5):669-74. PMC: 1463853. DOI: 10.1111/j.1365-2125.1985.tb02694.x. View

Sudlow G, Birkett D, Wade D . Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol. 1976; 12(6):1052-61. View

10.

OReilly R . Interaction of several coumarin compounds with human and canine plasma albumin. Mol Pharmacol. 1971; 7(2):209-18. View

11.

Foster R, Jamali F, Russell A, Alballa S . Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses. J Pharm Sci. 1988; 77(1):70-3. DOI: 10.1002/jps.2600770113. View

12.

Muller N, Lapicque F, Monot C, Payan E, Dropsy R, Netter P . Stereoselective binding of etodolac to human serum albumin. Chirality. 1992; 4(4):240-6. DOI: 10.1002/chir.530040407. View

13.

Monot C, Netter P, Stalars M, Martin J, Royer R, Gaucher A . Difficulties in applying the Scatchard model of ligand binding to proteins--proposal of new mathematical tools--application to salicylates. J Pharm Sci. 1983; 72(1):35-41. DOI: 10.1002/jps.2600720109. View

14.

Jamali F . Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs. Eur J Drug Metab Pharmacokinet. 1988; 13(1):1-9. DOI: 10.1007/BF03189920. View

15.

Wanwimolruk S, Brooks P, Birkett D . Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. Br J Clin Pharmacol. 1983; 15(1):91-4. PMC: 1427843. DOI: 10.1111/j.1365-2125.1983.tb01469.x. View

16.

Sioufi A, Colussi D, Marfil F, Dubois J . Determination of the (+)- and (-)-enantiomers of pirprofen in human plasma by high-performance liquid chromatography. J Chromatogr. 1987; 414(1):131-7. DOI: 10.1016/0378-4347(87)80031-2. View

17.

Day R, Furst D, Dromgoole S, Kamm B, Roe R, Paulus H . Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clin Pharmacol Ther. 1982; 31(6):733-40. DOI: 10.1038/clpt.1982.103. View

18.

Williams K, Day R . The contribution of enantiomers to variability in response to anti-inflammatory drugs. Agents Actions Suppl. 1988; 24:76-84. DOI: 10.1007/978-3-0348-9160-8_7. View

19.

Meffin P, Sallustio B, Purdie Y, Jones M . Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. I. 2-Phenylpropionic acid disposition. J Pharmacol Exp Ther. 1986; 238(1):280-7. View

20.

Netter P, Monot C, Stalars M, Mur J, Royer R, Faure G . Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis. Eur J Drug Metab Pharmacokinet. 1984; 9(2):109-16. DOI: 10.1007/BF03189613. View